Login to Your Account

Clinic Roundup

Wednesday, October 10, 2012
• Oculus Innovative Sciences Inc., of Petaluma, Calif., said results of its open-label pilot study testing Microcyn Technology-based Atrapro Antipruritic Hydrogel in combination with Neosalus Cream in atopic dermatitis demonstrated a statistically significant 50 percent reduction in the body surface area of the atopic dermatitis from baseline to week four.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription